Rfg Advisory, LLC Pds Biotechnology Corp Transaction History
Rfg Advisory, LLC
- $3.18 Billion
- Q3 2024
A detailed history of Rfg Advisory, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Rfg Advisory, LLC holds 10,000 shares of PDSB stock, worth $14,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$14,500% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.06MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$706,1020.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$601,9130.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$339,6030.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA134KShares$194,6770.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $41.3M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...